Detalles de la búsqueda
1.
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 329(15): 1271-1282, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071094
2.
A modified MethyLight assay predicts the clinical outcomes of anti-epidermal growth factor receptor treatment in metastatic colorectal cancer.
Cancer Sci
; 113(3): 1057-1068, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962023
3.
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.
Cancer Sci
; 112(4): 1567-1578, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548159
4.
Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203).
Tohoku J Exp Med
; 254(1): 49-55, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34053967
5.
Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03).
Support Care Cancer
; 28(8): 3649-3657, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31811480
6.
Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis.
Tohoku J Exp Med
; 245(2): 123-129, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29937450
7.
Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study.
Tohoku J Exp Med
; 245(1): 21-28, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29743448
8.
[Complete resection of liver metastases of colorectal cancer after high efficacy bevacizumab, S-1, and CPT -11 combination chemotherapy].
Gan To Kagaku Ryoho
; 42(1): 101-4, 2015 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-25596689
9.
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
Nat Med
; 30(3): 730-739, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347302
10.
Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6-NTRK3 positive metastatic salivary secretory carcinoma: A case series.
Head Neck
; 45(5): E10-E15, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36924196
11.
Multiple cavitary lung lesions from colorectal cancer responding to chemotherapy.
Respir Med Case Rep
; 44: 101865, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37214592
12.
Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201.
J Gastrointest Oncol
; 14(2): 676-691, 2023 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37201044
13.
Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients.
Oncology
; 83(2): 101-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22777333
14.
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial.
Anticancer Res
; 42(4): 2009-2015, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347022
15.
Curcumin analog GO-Y030 is a novel inhibitor of IKKß that suppresses NF-κB signaling and induces apoptosis.
Cancer Sci
; 102(5): 1045-51, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21272158
16.
Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo.
BMC Pharmacol
; 11: 4, 2011 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21619659
17.
Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial.
Eur J Cancer
; 154: 296-306, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34304054
18.
Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers.
Cancer Chemother Pharmacol
; 88(3): 393-402, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028598
19.
Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
Bioorg Med Chem
; 18(3): 1083-92, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20060305
20.
[Thyroid dysfunction (hypothyroidism and hyperthyroidism)].
Nihon Rinsho
; 73 Suppl 2: 422-5, 2015 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-25831795